| abstract |
The invention provides a pharmaceutical product comprising, in combination: (1) a specific glucocorticoid receptor agonist and (2) a β2 adrenergic receptor agonist, a β2 adrenergic receptor agonist / dual M3 receptor antagonist, a muscarinic antagonist, a p38 kinase inhibitor, a neutrophil elastase inhibitor, a PDE4 phosphodiesterase inhibitor, an IKK2 kinase inhibitor or a non-steroidal glucocorticoid receptor agonist, and the use of the product in the treatment of respiratory diseases. |